A randomized multicenter open label phase II study to determine the safety and efficacy of induction therapy with imatinib (Glivec, formerly STI571) in comparison with standard induction chemotherapy in elderly (>55 years) patients with Philadelphia (Q44675415)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized multicenter open label phase II study to determine the safety and efficacy of induction therapy with imatinib (Glivec, formerly STI571) in comparison with standard induction chemotherapy in elderly (>55 years) patients with Philadelphia |
scientific article |
Statements
1 reference
A randomized multicenter open label phase II study to determine the safety and efficacy of induction therapy with imatinib (Glivec, formerly STI571) in comparison with standard induction chemotherapy in elderly (>55 years) patients with Philadelphia (English)
1 reference
1 reference
B Wassmann
1 reference
N Gökbuget
1 reference
U J Scheuring
1 reference
A Binckebanck
1 reference
R Reutzel
1 reference
H Gschaidmeier
1 reference
D Hoelzer
1 reference
GMALL Study Group
1 reference
28 August 2003
1 reference
1 reference
82
1 reference
11
1 reference
716-720
1 reference
Identifiers
1 reference
1 reference